A big chunk of this article's message is that those considerations seem to not have anywhere near as much of an effect as currently assumed. (EpiPens viable 50 months past their marked date)

I would push two prongs: reinforce that expiration dates are serious, and at the same time test and extend any/all dates to the actual behavior of each drug. turn a one year into 5, 10, 20? Hell yes.

Pretty obvious that big chunks of the health care system are rigged for profit, not efficiency or usefulness.

I don't completely agree with the article's message. I think people who deal with statistical quantities of product and do extensive quality control testing probably have some wisdom about what's really safe. The article refers to a paper (which I've skimmed) that leaves a bunch of unanswered important questions.